中华心血管病杂志
中華心血管病雜誌
중화심혈관병잡지
Chinese Journal of Cardiology
2008年
4期
297-299
,共3页
莫安胜%林辉%王风%林英忠%温绍科%周一凡
莫安勝%林輝%王風%林英忠%溫紹科%週一凡
막안성%림휘%왕풍%림영충%온소과%주일범
心肌梗死%休克,心原性%治疗结果
心肌梗死%休剋,心原性%治療結果
심기경사%휴극,심원성%치료결과
Myocardial infarction%Shock,cardiogenic%Treatment outcome
目的 评价急性心肌梗死合并心原性休克47例患者的临床疗效,寻求降低病死率、改善预后的措施.方法 回顾性分析2002年1月至2007年5月共47例心肌梗死合并心原性休克患者,运用心血管活性药物、主动脉内球囊反搏(IABP)、介入手术或冠状动脉旁路移植术的治疗效果.结果 IABP治疗47例(100%),再血管化治疗41例(87.3%),死亡17例(36.2%).经药物和IABP治疗,在接受再血管化前死亡的患者占死亡数的35.3%(6/17),再血管化后死亡的患者占死亡数的64.7%(11/17).死于心功能衰竭者9例,死于肾功能衰竭和呼吸功能衰竭者8例.11例出现急性肾功能衰竭的患者全部死亡.急性肾功能衰竭(r=0.734,P=0.000)、急性呼吸功能衰竭(r=0.606,P=0.000)和糖尿病(r=0.372,P=0.012)与死亡有相关关系.结论 尽管急性心肌梗死合并心原性休克的治疗有了很大的发展,但病死率仍然较高,主要死因是急性心力衰竭、急性肾功能衰竭和急性呼吸功能衰竭.要进一步降低急性心肌梗死合并心原性休克患者住院病死率,可能需要更好的循环辅助装置及加强重要器官的保护.
目的 評價急性心肌梗死閤併心原性休剋47例患者的臨床療效,尋求降低病死率、改善預後的措施.方法 迴顧性分析2002年1月至2007年5月共47例心肌梗死閤併心原性休剋患者,運用心血管活性藥物、主動脈內毬囊反搏(IABP)、介入手術或冠狀動脈徬路移植術的治療效果.結果 IABP治療47例(100%),再血管化治療41例(87.3%),死亡17例(36.2%).經藥物和IABP治療,在接受再血管化前死亡的患者佔死亡數的35.3%(6/17),再血管化後死亡的患者佔死亡數的64.7%(11/17).死于心功能衰竭者9例,死于腎功能衰竭和呼吸功能衰竭者8例.11例齣現急性腎功能衰竭的患者全部死亡.急性腎功能衰竭(r=0.734,P=0.000)、急性呼吸功能衰竭(r=0.606,P=0.000)和糖尿病(r=0.372,P=0.012)與死亡有相關關繫.結論 儘管急性心肌梗死閤併心原性休剋的治療有瞭很大的髮展,但病死率仍然較高,主要死因是急性心力衰竭、急性腎功能衰竭和急性呼吸功能衰竭.要進一步降低急性心肌梗死閤併心原性休剋患者住院病死率,可能需要更好的循環輔助裝置及加彊重要器官的保護.
목적 평개급성심기경사합병심원성휴극47례환자적림상료효,심구강저병사솔、개선예후적조시.방법 회고성분석2002년1월지2007년5월공47례심기경사합병심원성휴극환자,운용심혈관활성약물、주동맥내구낭반박(IABP)、개입수술혹관상동맥방로이식술적치료효과.결과 IABP치료47례(100%),재혈관화치료41례(87.3%),사망17례(36.2%).경약물화IABP치료,재접수재혈관화전사망적환자점사망수적35.3%(6/17),재혈관화후사망적환자점사망수적64.7%(11/17).사우심공능쇠갈자9례,사우신공능쇠갈화호흡공능쇠갈자8례.11례출현급성신공능쇠갈적환자전부사망.급성신공능쇠갈(r=0.734,P=0.000)、급성호흡공능쇠갈(r=0.606,P=0.000)화당뇨병(r=0.372,P=0.012)여사망유상관관계.결론 진관급성심기경사합병심원성휴극적치료유료흔대적발전,단병사솔잉연교고,주요사인시급성심력쇠갈、급성신공능쇠갈화급성호흡공능쇠갈.요진일보강저급성심기경사합병심원성휴극환자주원병사솔,가능수요경호적순배보조장치급가강중요기관적보호.
Objective To evaluate the clinical outcomes of patients with acute myocardial infarction(AMI)complicating cardiogenic shock underwent various treatments.Methods From January,2002 to May,2007,47 AMI patients with cardiogenic shock were treated in our department by optimal medication (dopamine,epinephrine,norepinephrine,etc.),intrar-aortic balloon pump(IABP),mechanical ventilation when indicated,percutaneous coronary intervention(PCI)or coronary artery bypass graft (CABG).Outcome and factors related to mortality for these patients were analyzed in this retrospective study.Results Besides optimal medication and IABP in all patients,31 patients underwent PCI(66.0%),6 patients received emergency CABG(12.8%).The overall in-hospital mortality rate was 36.2%(17/47),6 patients(14.9%)died before coronary revascularization and 11 patients(21.3%)died after revascularization.Nine patients died of pump failure and 8 patients died of renal and(or)respiratory failure.Regression analysis showed that acute renal failure(r=0.734,P=0.000),acute respiratory failure (r=0.606,P=0.000)and diabetes(r=0.372,P=0.012)were positively related to in-hospital mortality.Conclusion Despite improvements in treatment options for AMI patients complicating cardiogenic shock,in-hospital mortality remained high,especially for patients complicating further with acute renal failure and acute respiratory failure.